OSCP1 (Oscillating Chloroplast Senescence Protein 1 Homolog), also known as OSBP2 (Oxysterol Binding Protein 2), is a gene that encodes a protein with homology to plant oscillating chloroplast senescence proteins. It has been implicated in mitochondrial function and dopaminergic neuron survival, making it a gene of interest in neurodegenerative disease research[1].
| Property | Value |
|---|---|
| Gene Symbol | OSCP1 |
| Gene Name | Oscillating Chloroplast Senescence Protein 1 Homolog |
| Aliases | OSBP2, ORP-4 |
| Chromosomal Location | 4p16.3 |
| NCBI Gene ID | 120863 |
| OMIM ID | 613417 |
| Ensembl ID | ENSG00000178199 |
| UniProt ID | Q8N9U4 |
| Gene Type | Protein Coding |
OSCP1 encodes a protein belonging to the oxysterol-binding protein (OSBP) family. These proteins are characterized by their ability to bind oxysterols, which are oxidized derivatives of cholesterol, and are involved in lipid metabolism, transport, and signaling pathways[2].
The OSCP1 protein contains:
OSCP1 is primarily localized to mitochondria in neuronal cells. Studies have shown that it interacts with mitochondrial proteins involved in:
OSCP1 is expressed in various tissues with high mitochondrial content, including:
Within the brain, OSCP1 expression is enriched in dopaminergic neurons, which are particularly vulnerable in Parkinson's disease. This expression pattern has prompted investigation into its potential role in PD pathogenesis[4].
OSCP1 variants have been associated with Parkinson's disease risk in genome-wide association studies (GWAS). While the exact mechanism is not fully understood, several lines of evidence suggest OSCP1 may be involved in PD pathogenesis:
Several mechanisms have been proposed for OSCP1's involvement in neurodegeneration:
While OSCP1 is not currently a primary drug target, understanding its function may contribute to:
OSCP1 interacts with several proteins relevant to neurodegeneration:
Studies in model organisms have provided insights into OSCP1 function:
Nalls MA et al. Large-scale meta-analysis of Parkinson's disease GWAS. Movement Disorders. 2019. ↩︎
Beziau A et al. Oxysterol-binding protein family: lipid sensors and metabolic regulators. Cellular and Molecular Life Sciences. 2020. ↩︎
Liu Y et al. Mitochondrial dysfunction and neurodegeneration: the role of mitochondrial dynamics-related proteins. Frontiers in Cell and Developmental Biology. 2020. ↩︎
Chang D et al. A meta-analysis of Parkinson's disease genome-wide association study data. Annals of Neurology. 2017. ↩︎
Zhou Q et al. Lipid metabolism in neurodegeneration: from pathophysiology to therapeutic strategies. Frontiers in Neuroscience. 2021. ↩︎
Pickrell AM et al. Mitochondrial quality control: an emerging pathway in neurodegeneration. Neuron. 2015. ↩︎